Table 3 Differentiation and comparison of the BSCH-defined cohort of ET patients1, 2 by applying the diagnostic criteria of the WHO classification3

From: Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria

 

BCSH-defined ET (n=238)

WHO-defined ET (n=232)

ET

141 (59.2%)

232 (100%)

prePMF

77 (32.4%)

0

PV

16 (6.7%)

0

PMF

4 (1.7%)

0

  1. Abbreviations: BCSH, British Committee of Standards in Haematology; ET, essential thrombocythemia; PMF, advanced PMF; prePMF, prefibrotic primary myelofibrosis; PV, polycythemia vera.
Back to article page